{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000054.3:c.161A>T",
          "cDNA Change": {
            "transcript": "NM_000054.3",
            "ref": "A",
            "alt": "T",
            "position": "161"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "F",
            "position": "54"
          },
          "Description in input context": "c.161A>T (p.L54F)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0002798"
  },
  "Experiment Method": [
    {
      "Assay Method": "2-D DIGE coupled with LC-MS/MS",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "Human neuroblastoma cell line"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000054.3:c.161A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "differential mitochondrial protein expression",
          "Result Description": "WT alpha-synuclein caused significant changes in mitochondrial proteins, while A53T showed fewer effects."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "Not mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels similar to baseline conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly different protein expression levels compared to baseline conditions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "2-D DIGE coupled with LC-MS/MS is a standard method for proteomic analysis in Parkinson's disease studies."
      }
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "Human neuroblastoma cell line"
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000054.3:c.161A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "differential protein expression",
          "Result Description": "Western blot analysis confirmed differential expression of mitochondrial proteins between WT and A53T alpha-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "Not mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels similar to baseline conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly different protein expression levels compared to baseline conditions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Western blot is a standard method for studying protein expression in Parkinson's disease studies."
      }
    }
  ]
}